Our data demonstrate the existence of important alterations in the phenotype of peripheral B cells from RA patients, involving the expression of the co-stimulatory molecule CD86 and the inhibitory receptor FcγRIIb, the latter being associated with high titers of autoantibodies. The gene discussed is FCGR2B; the disease is rheumatoid arthritis.